Advertisement One week ago, the FDA approved the updated versions for Pfizer/BioNTech and Moderna, an mRAN. They are now available in some pharmacies. All these vaccines include a monovalent ...

Dr. Jeffrey Barke, a California primary care physician, said the FDA had no right to grant emergency use authorization because the public health emergency declared for the pandemic expired in May ...

The Food and Drug Administration (FDA) approved updated COVID shots from Pfizer and Moderna Thursday, setting the stage for a vaccine rollout in the coming weeks. “In June, the FDA asked that ...

“We strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants,” said FDA vaccine chief Dr ...

The FDA on Thursday said its marketing authorization of the product was its first ever for a over-the-counter hearing aid software device. Related Apple to release AirPods with built-in hearing ...

There is an opportunity to fix this by encouraging regulators such as the FDA and the EMA to agree on an aligned regulatory approach to the development of complex generics. In 2021, the FDA and ...

After the U.S. Food and Drug Administration (FDA) approved the emergency use of the 2024-2025 COVID-19 vaccines many questions are beginning to circulate. In the FDA's press release on Aug. 22 ...

Both Pfizer and Moderna’s shots target the KP.2 COVID-19 variant—JN.1 is the parent variant of KP.2. The FDA in June asked vaccine makers to create shots that target the coronavirus’ JN.

Cresilon has raised about $130 million in venture capital dollars and grown to comprise more than 80 employees — and last week, the company nabbed its second FDA clearance for human use.

Democratic Reps. Ayanna Pressley of Massachusetts and Shontel Brown of Ohio pressed the FDA in a letter to finalize the proposed rule for banning certain salon-grade and at-home hair straighteners.

The FDA has approved the combination of Rybrevant plus Lazcluze for first-line treatment of adult patients with locally advanced or metastatic non-small-cell lung cancer, or NSCLC, with epidermal ...

1 strain of the virus. "Today's authorization provides an additional COVID-19 vaccine option," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. Doses are on ...